Abstract
Data from observational studies have raised concerns about the safety of treatment with antipsychotic agents (APs) in elderly patients with dementia, but this area has been insufficiently investigated. We performed a head-to-head comparison of the risk of major adverse cardiovascular events and noncardiovascular mortality associated with individual APs (ziprasidone, olanzapine, risperidone, quetiapine, levomepromazine, chlorprothixen, flupentixol, and haloperidol) in Danish treatment-naïve patients aged ≥70 years. We followed all treatment-naïve Danish citizens aged ≥70 years that initiated treatment with APs for the first time between 1997 and 2011 (n=91 774, mean age 82±7 years, 35 474 [39%] were men). Incidence rate ratios associated with use of different APs were assessed by multivariable time-dependent Poisson regression models. For the first 30 days of treatment, compared with risperidone, incidence rate ratios of major adverse cardiovascular events were higher with use of levomepromazine (3.80, 95% CI 3.43 to 4.21) and haloperidol (1.85, 95% CI 1.67 to 2.05) and lower for treatment with flupentixol (0.54, 95% CI 0.45 to 0.66), ziprasidone (0.31, 95% CI 0.10 to 0.97), chlorprothixen (0.76, 95% CI 0.61 to 0.95), and quetia...Continue Reading
References
May 9, 2001·Neurology·R S DoodyJ L Cummings
Jul 12, 2002·Drugs·Peter M Haddad, Ian M Anderson
Nov 25, 2003·The Journal of Clinical Psychiatry·Rosa LiperotiRoberto Bernabei
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Jan 26, 2005·BMJ : British Medical Journal·Sudeep S GillMuhammad Mamdani
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel
Dec 2, 2005·The New England Journal of Medicine·Philip S WangM Alan Brookhart
Feb 28, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sebastian SchneeweissPhilip S Wang
May 5, 2007·Neuroepidemiology·Lars-Henrik KrarupThomas Truelsen
Jun 6, 2007·Annals of Internal Medicine·Sudeep S GillPaula A Rochon
Jul 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dilip V JesteKristine Yaffe
Apr 10, 2008·Pharmacoepidemiology and Drug Safety·Hugo LövheimYngve Gustafson
Aug 12, 2008·Journal of the American Geriatrics Society·Soko SetoguchiSebastian Schneeweiss
Aug 30, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Elmira ValiyevaGeoffrey M Anderson
Jan 14, 2009·Lancet Neurology·Clive BallardUNKNOWN DART-AD investigators
Jan 16, 2009·The New England Journal of Medicine·Wayne A RayC Michael Stein
Nov 13, 2009·The Journal of Clinical Psychiatry·Rosa LiperotiGiovanni Gambassi
May 22, 2010·Journal of the American Geriatrics Society·Rebecca C RossomMaurice W Dysken
May 14, 2011·The American Journal of Geriatric Pharmacotherapy·Sandhya MehtaRajender R Aparasu
May 31, 2011·BMC Medical Research Methodology·Sandra K ThygesenHenrik T Sørensen
Jul 28, 2011·CNS Drugs·James J Gugger
Oct 29, 2011·Stroke; a Journal of Cerebral Circulation·Shirley WangMalcolm Maclure
Mar 1, 2012·BMJ : British Medical Journal·K F HuybrechtsS Schneeweiss
Mar 28, 2012·Archives of Internal Medicine·Antoine ParienteYola Moride
Jan 12, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Martin PrinceCleusa P Ferri
Nov 11, 2014·Journal of Multidisciplinary Healthcare·Matisyahu ShulmanAleksey Tentler
Citations
Feb 26, 2016·Expert Review of Neurotherapeutics·Stefan Hermanowicz, Neal Hermanowicz
Aug 1, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Niklas SchmedtTania Schink
Mar 10, 2016·Journal of Clinical Pharmacology·H Karl Greenblatt, David J Greenblatt
Nov 5, 2016·Drugs & Aging·Maryse Lapeyre-Mestre
Jan 13, 2017·Current Opinion in Psychiatry·Orestes V ForlenzaFlorindo Stella
Jun 15, 2017·Journal of Psychopharmacology·Kai-Lin HuangRobert Stewart
Oct 18, 2018·Rejuvenation Research·Svetlana ZalomonsonYan Press
Feb 13, 2019·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Raya Elfadel KheirbekMaria Llorente
Aug 7, 2017·European Journal of Clinical Pharmacology·Marta MiaronsLaia Rofes
May 15, 2018·The Nurse Practitioner·Sushila Pathak, Elsie Duff
Nov 7, 2018·The Mental Health Clinician·Monica Mathys
Dec 10, 2016·Journal of Alzheimer's Disease : JAD·Marjaana KoponenSirpa Hartikainen
Jun 30, 2018·The Mental Health Clinician·Monica MathysJasmine Carter
Mar 20, 2020·BMC Health Services Research·Jong-Yi WangYi-Jhen Li
Aug 2, 2020·CNS Drugs·Han Eol JeongJu-Young Shin
Mar 29, 2018·Drugs & Aging·Amy ZhouTanya M Wildes
Sep 12, 2018·Therapeutic Innovation & Regulatory Science·Donatas StakišaitisRimas Jonas Jankūnas
Aug 7, 2021·Journal of Clinical Nursing·Shudan XiaoBo Li